Literature DB >> 9186912

Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants.

F Karpe1, T Olivecrona, A Hamsten, M Hultin.   

Abstract

The size of cholesterol-rich lipoprotein particles is a strong determinant of whether they may be deposited in the arterial wall and by this become potentially atherogenic. This study deals with the in vivo transformation of larger-sized chylomicrons and chylomicron remnants to smaller-sized remnants. Twelve healthy men aged 22 to 45 years were given a fatty meal to which retinyl palmitate (RP) had been added. Plasmapheresis was performed 4 1/2 h after meal intake to isolate approximately 400 ml plasma. The RP-rich plasma was re-injected to the subject 24 h later. The RP content was determined in whole plasma and in Svedberg flotation rate fractions (Sf) > 400, Sf 60-400 and Sf 20-60. A compartmental model was developed for the kinetic analysis. Lipoprotein fractions showed minimal signs of aggregation, thus arguing for well-preserved postprandial lipoproteins. Approximately a fourth [23% (4-68%)] of the RP-containing lipoproteins in the Sf > 400 pool was converted to smaller species (Sf 60-400). Conversion of material from the Sf 60-400 to the Sf 20-60 fraction could not be detected. In a second study a large bolus dose of a triglyceride emulsion (Intralipid) was injected to subjects shortly after the RP-labeled plasma to investigate the endothelial binding of the chylomicron/chylomicron remnants. RP material in the Sf > 400 fraction rapidly returned to plasma, arguing for margination of chylomicrons, whereas the corresponding effect was minimal in the Sf 60-400 and Sf 20-60 fractions. The formation of small chylomicron remnants from the larger chylomicron/chylomicron remnant species is limited and large chylomicron/chylomicron remnants are not evenly distributed in plasma, rather they show signs of being marginated to the vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186912

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

Review 1.  Postprandial lipoprotein metabolism: VLDL vs chylomicrons.

Authors:  Katsuyuki Nakajima; Takamitsu Nakano; Yoshiharu Tokita; Takeaki Nagamine; Akihiro Inazu; Junji Kobayashi; Hiroshi Mabuchi; Kimber L Stanhope; Peter J Havel; Mitsuyo Okazaki; Masumi Ai; Akira Tanaka
Journal:  Clin Chim Acta       Date:  2011-04-19       Impact factor: 3.786

2.  Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat.

Authors:  Chunyu Zheng; Katsunori Ikewaki; Brian W Walsh; Frank M Sacks
Journal:  J Lipid Res       Date:  2006-05-09       Impact factor: 5.922

3.  Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion.

Authors:  Y Park; B D Damron; J M Miles; W S Harris
Journal:  Lipids       Date:  2001-02       Impact factor: 1.880

4.  Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance.

Authors:  E J Parks; R M Krauss; M P Christiansen; R A Neese; M K Hellerstein
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

5.  Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids.

Authors:  Mirjana Pavlic; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

Review 6.  Diabetic dyslipidaemia: from basic research to clinical practice.

Authors:  M-R Taskinen
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

7.  Brief Communication: Discordant ability of the triglyceride to apolipoprotein B ratio to predict triglyceride-rich lipoprotein particle size in normal-weight and obese men.

Authors:  Miryam Amigo-Benavent; Laura Sinausia; Emilio Montero; Javier S Perona
Journal:  Exp Biol Med (Maywood)       Date:  2016-03-17

8.  Chylomicron metabolism in rats: kinetic modeling indicates that the particles remain at endothelial sites for minutes.

Authors:  Magnus Hultin; Roger Savonen; Olivier Chevreuil; Thomas Olivecrona
Journal:  J Lipid Res       Date:  2013-08-06       Impact factor: 5.922

9.  Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis.

Authors:  Dana Mahmood; Maria Grubbström; Lennart D I Lundberg; Gunilla Olivecrona; Thomas Olivecrona; Bernd G Stegmayr
Journal:  BMC Nephrol       Date:  2010-12-06       Impact factor: 2.388

10.  Postprandial triglyceride-rich lipoproteins induce hepatic insulin resistance in HepG2 cells independently of their receptor-mediated cellular uptake.

Authors:  Tobias Tatarczyk; Christian Ciardi; Andreas Niederwanger; Michael Kranebitter; Josef R Patsch; Michael T Pedrini
Journal:  Mol Cell Endocrinol       Date:  2011-06-15       Impact factor: 4.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.